Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-036001

Director bought 718 shares at an average $2.30 ($1,650)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jones James Director 2022-05-02 Purchase +30 $2.45 $74 20,713 D
Jones James Director 2022-05-03 Purchase +30 $2.42 $73 20,743 D
Jones James Director 2022-05-04 Purchase +30 $2.37 $71 20,773 D
Jones James Director 2022-05-05 Purchase +30 $2.35 $71 20,803 D
Jones James Director 2022-05-06 Purchase +30 $2.36 $71 20,833 D
Jones James Director 2022-05-09 Purchase +34 $2.63 $89 20,867 D
Jones James Director 2022-05-10 Purchase +34 $2.55 $87 20,901 D
Jones James Director 2022-05-11 Purchase +34 $2.37 $81 20,935 D
Jones James Director 2022-05-12 Purchase +34 $2.23 $76 20,969 D
Jones James Director 2022-05-13 Purchase +34 $2.32 $79 21,003 D
Jones James Director 2022-05-16 Purchase +34 $2.31 $79 21,037 D
Jones James Director 2022-05-17 Purchase +34 $2.35 $80 21,071 D
Jones James Director 2022-05-18 Purchase +34 $2.31 $79 21,105 D
Jones James Director 2022-05-19 Purchase +34 $2.29 $78 21,139 D
Jones James Director 2022-05-20 Purchase +34 $2.23 $76 21,173 D
Jones James Director 2022-05-23 Purchase +38 $2.17 $82 21,211 D
Jones James Director 2022-05-24 Purchase +38 $2.17 $82 21,249 D
Jones James Director 2022-05-25 Purchase +38 $2.15 $82 21,287 D
Jones James Director 2022-05-26 Purchase +38 $2.12 $81 21,325 D
Jones James Director 2022-05-27 Purchase +38 $2.13 $81 21,363 D
Jones James Director 2022-05-31 Purchase +38 $2.13 $81 21,401 D
Open-market purchases · 718 sh · avg $2.30 · $1,650
Loading xslF345X03/doc4.xml…